05B4 Whellan, David - Jefferson Medical College - Thomas Jefferson University
djw150

David J. Whellen, MD, MHS, FACC, FAHA

Contact Dr. Whellen

925 Chestnut Street
Mezzanine
Philadelphia, PA 19107

(215) 955-2636
(215) 503-7420 fax

Most Recent Peer-reviewed Publications

  1. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)
  2. Heart Failure Patient Adherence. Epidemiology, Cause, and Treatment
  3. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics
  4. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting
  5. Physical activity to combat depression in chronic heart failure: Reply
  6. Relation between volume of exercise and clinical outcomes in patients with heart failure
  7. Long-term exercise training and adheren It is not just exercise
  8. Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: Findings from HF-ACTION
  9. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization
  10. Saphenous vein graft disease: Review of pathophysiology, prevention, and treatment
  11. Effects of exercise training on depressive symptoms in patients with chronic heart failure: The HF-ACTION randomized tria
  12. Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) Trial
  13. Predicting costs among medicare beneficiaries with heart failure
  14. Change in intrathoracic impedance measures during acute decompensated heart failure admission: Results from the diagnostic data for discharge in heart failure patients (3D-HF) pilot study
  15. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
  16. Introduction of the tools for economic analysis of patient management interventions in heart failure costing tool a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions
  17. Galectin-3 in ambulatory patients with heart failure results from the HF-ACTION study
  18. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction the HF-ACTION predictive risk score model
  19. Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercis 029B e Training study
  20. Reporting of Clinical Trials: Publication, Authorship, and Trial Registration
0